FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912584343> ?p ?o ?g. }

• W2912584343 abstract "Introduction: Stroke is a devastating disease at any age. There are few studies on utility of intravenous thrombolysis (tPA) or intra-arterial thrombectomy (IAT) in pediatric acute ischemic stroke (AIS). Hypothesis: To describe and compare clinical outcomes of pediatric AIS patients who did and did not receive tPA+/-IAT. Methods: We retrospectively reviewed all pediatric AIS cases, aged 0-17, from the 2006-2010 Nationwide Inpatient Survey, a 20% stratified sample of all U.S. community hospitals. Demographics, outcomes, cost of stay, and comorbidities were assessed. Results: Overall, 20,587 patients were analyzed. Mean age was 6.0 years (SD 13.9); female 43.9%; white 47.7%. Of those, 198 patients received intervention: 169 tPA, 5 IAT, and 24 tPA+IAT. Treated patients were older (10.0 years vs 5.9 years, p<0.0001). Mortality for pediatric AIS patients was 7.8%; 13.8% in tPA patients compared to 7.7% in the untreated. No deaths in the IAT group. Non-treated patients were more likely to be discharged home than those receiving tPA+/-IAT (67.8% vs. 47.5%, p<0.0001). Cost for treated patients was higher ($200,346 vs. $123,015, p=0.01). Intracerebral hemorrhage (ICH) was more common in treated patients (10.1% vs. 3.8%, p<0.0001). Comorbidities included Moyamoya disease (12.4%), cardiac valvular disease (6.6%), and sickle cell disease (6.5%). The treated group had higher prevalence of pneumonia/influenza (17.2% vs. 7.6%, p<0.0001), procoagulable conditions (15.2% vs. 2%, p<0.0001), and cardiac valvular disease (15.2% vs. 6.5%, p<0.0001). Conclusions: In the pediatric AIS population, tPA was associated with increased mortality. Treatment with tPA+/-IAT was associated with decreased discharge home, increased cost, and higher prevalence of ICH. Prevalence of ICH is not explained by the presence of Moyamoya or sickle cell as those patients were less likely to receive treatment. Limitations of this study include small numbers of treated patients, lack of data on stroke severity or functional outcome, and data from years prior to newer thrombectomy devices. Studies of AIS treatment in adults cannot necessicarily be extrapolated given the difference in etiologies of pediatric AIS. Pediatric AIS is on the rise, so more research for effective treatment is necessary." @default.
• W2912584343 created "2019-02-21" @default.
• W2912584343 creator A5017125448 @default.
• W2912584343 creator A5017171393 @default.
• W2912584343 creator A5036011056 @default.
• W2912584343 creator A5049659726 @default.
• W2912584343 creator A5050409727 @default.
• W2912584343 creator A5052710260 @default.
• W2912584343 creator A5073992085 @default.
• W2912584343 creator A5077632438 @default.
• W2912584343 date "2017-02-01" @default.
• W2912584343 modified "2023-09-24" @default.
• W2912584343 title "Abstract WMP115: Thrombolysis and Thrombectomy in Pediatric Ischemic Stroke" @default.
• W2912584343 doi "https://doi.org/10.1161/str.48.suppl_1.wmp115" @default.
• W2912584343 hasPublicationYear "2017" @default.
• W2912584343 type Work @default.
• W2912584343 sameAs 2912584343 @default.
• W2912584343 citedByCount "0" @default.
• W2912584343 crossrefType "journal-article" @default.
• W2912584343 hasAuthorship W2912584343A5017125448 @default.
• W2912584343 hasAuthorship W2912584343A5017171393 @default.
• W2912584343 hasAuthorship W2912584343A5036011056 @default.
• W2912584343 hasAuthorship W2912584343A5049659726 @default.
• W2912584343 hasAuthorship W2912584343A5050409727 @default.
• W2912584343 hasAuthorship W2912584343A5052710260 @default.
• W2912584343 hasAuthorship W2912584343A5073992085 @default.
• W2912584343 hasAuthorship W2912584343A5077632438 @default.
• W2912584343 hasConcept C126322002 @default.
• W2912584343 hasConcept C127413603 @default.
• W2912584343 hasConcept C144024400 @default.
• W2912584343 hasConcept C149923435 @default.
• W2912584343 hasConcept C187212893 @default.
• W2912584343 hasConcept C194828623 @default.
• W2912584343 hasConcept C2779546523 @default.
• W2912584343 hasConcept C2779581417 @default.
• W2912584343 hasConcept C2780084366 @default.
• W2912584343 hasConcept C2780645631 @default.
• W2912584343 hasConcept C3020199598 @default.
• W2912584343 hasConcept C500558357 @default.
• W2912584343 hasConcept C541997718 @default.
• W2912584343 hasConcept C71924100 @default.
• W2912584343 hasConcept C78519656 @default.
• W2912584343 hasConceptScore W2912584343C126322002 @default.
• W2912584343 hasConceptScore W2912584343C127413603 @default.
• W2912584343 hasConceptScore W2912584343C144024400 @default.
• W2912584343 hasConceptScore W2912584343C149923435 @default.
• W2912584343 hasConceptScore W2912584343C187212893 @default.
• W2912584343 hasConceptScore W2912584343C194828623 @default.
• W2912584343 hasConceptScore W2912584343C2779546523 @default.
• W2912584343 hasConceptScore W2912584343C2779581417 @default.
• W2912584343 hasConceptScore W2912584343C2780084366 @default.
• W2912584343 hasConceptScore W2912584343C2780645631 @default.
• W2912584343 hasConceptScore W2912584343C3020199598 @default.
• W2912584343 hasConceptScore W2912584343C500558357 @default.
• W2912584343 hasConceptScore W2912584343C541997718 @default.
• W2912584343 hasConceptScore W2912584343C71924100 @default.
• W2912584343 hasConceptScore W2912584343C78519656 @default.
• W2912584343 hasIssue "suppl_1" @default.
• W2912584343 hasLocation W29125843431 @default.
• W2912584343 hasOpenAccess W2912584343 @default.
• W2912584343 hasPrimaryLocation W29125843431 @default.
• W2912584343 hasVolume "48" @default.
• W2912584343 isParatext "false" @default.
• W2912584343 isRetracted "false" @default.
• W2912584343 magId "2912584343" @default.
• W2912584343 workType "article" @default.